1123: Bcl-2 and Bax Predict Prostate Cancer Outcome in Men Treated With Androgen Deprivation and Radiotherapy on RTOG 92-02

Journal article

A Pollack, J Moughan, L Khor, T Al-Saleem, M.E Hammond, V Venkatesan, S.A Rosenthal, G.E Hanks, W Shipley and H Sandler

International journal of radiation oncology, biology, physics, Vol.66(3), pp.S201-S201

2006

Metrics

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.1398 Protein Kinase CK2
Web Of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 1123: Bcl-2 and Bax Predict Prostate Cancer Outcome in Men Treated With Androgen Deprivation and Radiotherapy on RTOG 92-02
Creators: A Pollack - Fox Chase Cancer Center, Philadelphia, PA
J Moughan - Radiation Therapy Oncology Group, Philadelphia, PA
L Khor - Fox Chase Cancer Center, Philadelphia, PA
T Al-Saleem - Fox Chase Cancer Center, Philadelphia, PA
M.E Hammond - LDS Hospital, Salt Lake City, UT
V Venkatesan - University of Western Ontario, London, ON, Canada
S.A Rosenthal - Radiological Associates, Sacramento, CA
G.E Hanks - Fox Chase Cancer Center, Philadelphia, PA
W Shipley - Massachusetts General Hospital, Boston, MA
H Sandler - University of Michigan, Ann Arbor, MI
Publication Details: International journal of radiation oncology, biology, physics, Vol.66(3), pp.S201-S201
Publisher: Elsevier Inc
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600253602976